DYSIS Medical Raises £18 Million to Accelerate Growth
Edinburgh – July 9th, 2018 – DYSIS Medical Ltd, the developer of the innovative DYSIS Ultra colposcope used in cervical cancer screening, announces today the completion of an £18 million ($25 million) investment. Within the past year, DYSIS Medical has made significant strides and achieved key […]
NICE Upgrades Guidance on DYSIS.
NICE upgrades guidance on DYSIS. Edinburgh – April 25th, 2018– DYSIS Medical Ltd, announces today that the National Institute for Health and Care Excellence (NICE) has updated its original 2012 guidance on adjunctive colposcopy technologies, following a robust and in-depth analysis for a range of technologies. NICE reviewed […]